NDC 70954-041

Rifabutin

Rifabutin

Rifabutin is a Oral Capsule in the Human Prescription Drug category. It is labeled and distributed by Novitium Pharma Llc. The primary component is Rifabutin.

Product ID70954-041_baf8ec98-bd0c-4b87-a7ee-813335431b89
NDC70954-041
Product TypeHuman Prescription Drug
Proprietary NameRifabutin
Generic NameRifabutin
Dosage FormCapsule
Route of AdministrationORAL
Marketing Start Date2021-12-17
Marketing CategoryANDA /
Application NumberANDA215041
Labeler NameNovitium Pharma LLC
Substance NameRIFABUTIN
Active Ingredient Strength150 mg/1
Pharm ClassesRifamycin Antimycobacterial [EPC],Rifamycins [CS]
NDC Exclude FlagN
Listing Certified Through2022-12-31

Packaging

NDC 70954-041-10

100 CAPSULE in 1 BOTTLE (70954-041-10)
Marketing Start Date2021-12-17
NDC Exclude FlagN
Sample Package?N

Drug Details

NDC Crossover Matching brand name "Rifabutin" or generic name "Rifabutin"

NDCBrand NameGeneric Name
10135-738RifabutinRifabutin
59762-1350Rifabutinrifabutin
60687-198rifabutinrifabutin
68180-285rifabutinrifabutin
70954-041RifabutinRifabutin
0013-5301Mycobutinrifabutin
55695-010Mycobutinrifabutin

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.